Post-IPO Equity Therapeutics Companies

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Elicera Therapeutics develops cell and gene therapies for cancer treatment, with a focus on CAR T-cell therapies and oncolytic viruses.

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.

Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Abivax develops medicines that alter the body's natural immune system mechanisms.

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.